We would love to hear your thoughts about our site and services, please take our survey here.
2m prescriptions for the drug.
We have the leading test to determine whether or not the drug can be taken by a patient without it proving fatal so theoretically every new patient taking the drug should do one of our tests beforehand.
How the number if new users relates to the 2m number is anyone's guess as some won't get the prescription if the test comes back saying it is harmful, some will have taken it before and some will be unaware of the test.
It does show that it is a market worth addressing though
cash covering operating costs and forecast to continue growing going forward
10000 samples will be carried out in october and speaking to govt about moonshot
When would these air miles have been clocked up during a global lockdown?
"the group recorded it's first profits on an EBITDA level"
I know covid is exciting but let's not forget about the very strong core business
What do people make of this facility that was taken out in mid April? If they need cash I would imagine that a placing would be high on their list of options after the recent strength. https://t.co/S3QVJVciTZ
After having spoken to AR and Mr Little at a previous presentation I think you are spot on the Nasdaq
The bigger question has to be why another company is able to use it to produce covid tests get we let it sit idle.
Clearly lots of manufacturing work to go around, YGEN should be able to fill their boots
He thinks that people are more likely to abort if they get a test saying that their child has downs. Fact is people would still have a test, which is more dangerous, if NIPT wasn't available.
Govt is initially buying 3 5m tests https://www.theguardian.com/world/2020/mar/29/the-two-tests-that-will-help-to-predict-spread-of-covid-19
The vast majority of his tips have tanked, the chance to book a profit against this one must have seemed too tempting. He also seems to have ethical issues around NIPT. Each to their own, now his followers are out the SP should recover from here.
17p fully diluted
This has proven to be a very leaky stock in the past so wouldn't be surprised if we hear some good news in the next few weeks